AMICUS THERAPEUTICS, INC. — Director's Dealing 2011

Apr 19, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AMICUS THERAPEUTICS INC (FOLD)
CIK: 0001178879
Period of Report: 2011-04-18

Reporting Person: Patterson Matthew R (Acting CEO & President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2011-04-18	Common Stock	A	50000	$0.00	Acquired	106547	Direct

Footnotes

F1: Mr. Patterson was awarded a grant of 50,000 shares of restricted stock on April 18, 2011. The shares will vest in full on October 18, 2012 and may vest earlier under certain circumstances. Until such time, these shares are subject to a risk of forfeiture.